Paradigm Capital Management Inc. NY lessened its holdings in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 0.6% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,959,900 shares of the software maker’s stock after selling 11,700 shares during the period. Allscripts Healthcare Solutions accounts for approximately 2.2% of Paradigm Capital Management Inc. NY’s investment portfolio, making the stock its 13th biggest holding. Paradigm Capital Management Inc. NY owned approximately 1.08% of Allscripts Healthcare Solutions worth $25,008,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Thrivent Financial For Lutherans raised its position in shares of Allscripts Healthcare Solutions by 255.4% during the 1st quarter. Thrivent Financial For Lutherans now owns 111,780 shares of the software maker’s stock worth $1,418,000 after acquiring an additional 80,330 shares in the last quarter. Neuburgh Advisers LLC raised its position in shares of Allscripts Healthcare Solutions by 4.1% during the 1st quarter. Neuburgh Advisers LLC now owns 12,070 shares of the software maker’s stock worth $153,000 after acquiring an additional 476 shares in the last quarter. Dalton Greiner Hartman Maher & Co. acquired a new stake in shares of Allscripts Healthcare Solutions during the 2nd quarter worth about $1,276,000. Canada Pension Plan Investment Board raised its position in shares of Allscripts Healthcare Solutions by 12.0% during the 1st quarter. Canada Pension Plan Investment Board now owns 82,200 shares of the software maker’s stock worth $1,042,000 after acquiring an additional 8,800 shares in the last quarter. Finally, OppenheimerFunds Inc. raised its position in shares of Allscripts Healthcare Solutions by 9.4% during the 1st quarter. OppenheimerFunds Inc. now owns 31,445 shares of the software maker’s stock worth $399,000 after acquiring an additional 2,701 shares in the last quarter.

Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) traded up 5.21% on Monday, hitting $13.73. The company’s stock had a trading volume of 2,090,666 shares. The company has a 50 day moving average of $12.77 and a 200 day moving average of $12.33. Allscripts Healthcare Solutions, Inc. has a 1-year low of $9.80 and a 1-year high of $13.97. The firm’s market cap is $2.48 billion.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Thursday, August 3rd. The software maker reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.15 by $0.04. The company had revenue of $426.10 million for the quarter, compared to analyst estimates of $424.94 million. Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The firm’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.14 earnings per share. Equities analysts forecast that Allscripts Healthcare Solutions, Inc. will post $0.62 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/11/allscripts-healthcare-solutions-inc-mdrx-shares-sold-by-paradigm-capital-management-inc-ny.html.

MDRX has been the topic of several research analyst reports. Morgan Stanley raised their target price on Allscripts Healthcare Solutions from $11.00 to $12.00 and gave the stock an “underweight” rating in a research report on Monday, August 7th. Cowen and Company raised Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $13.00 to $16.00 in a research report on Monday. Maxim Group restated a “buy” rating and set a $16.00 price target on shares of Allscripts Healthcare Solutions in a research note on Monday, May 15th. Piper Jaffray Companies restated a “hold” rating and set a $14.00 price target on shares of Allscripts Healthcare Solutions in a research note on Friday, July 21st. Finally, Jefferies Group LLC set a $17.00 price target on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research note on Friday, August 25th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and eleven have issued a buy rating to the company’s stock. Allscripts Healthcare Solutions has a consensus rating of “Buy” and an average target price of $14.81.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related stocks with our FREE daily email newsletter.